Across TCGA pan-cancer cohorts, ODF2 mass-spec protein differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of ODF2’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where ODF2 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ODF2 is over-expressed in tumor, although a few such as HNSC and OV show the opposite, repressed pattern.
HNSC and OV are the cancer types where ODF2 tumor–normal differential expression is most reproducible.